MYK-461: Phase I data

Top-line data from the open-label, U.S. Phase I MYK-461-001 trial in 15 patients with HCM showed

Read the full 160 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE